Horizon Pharma (HZNP) Stock: Gaining Big On Strong Earnings And Guidance

0

Horizon Pharma PLC (NASDAQ: HZNP) is having an overwhelmingly strong time in the pre-market hours this morning, and for good reason. The company reported its earnings for the second quarter, blowing away expectations on all accounts. Of course, this led to excitement among investors, sending the stock toward the top and prompting our friends at Trade Ideas to send the alert. At the moment (8:43), HZNP is trading at $14.51 per share after a gain of $1.81 per share or 14.25% thus far today.





HZNP Reports Strong Earnings

As mentioned above, Horizon Pharma is having an incredibly strong time in the pre-market hours today after reporting solid earnings. Here’s what we saw from the report…




  • Earnings Per Share – In terms of earnings per share, HZNP did overwhelmingly well in the second quarter. During the quarter, analysts expected that the company would generate earnings in the amount of $0.10. However, the company actually reported earnings in the amount of $0.41, blowing expectations out of the water.
  • Revenue – HZNP didn’t disappoint when it comes to revenue either. During the second quarter, analysts expected that the company would generate revenue in the amount of $237.1 million. However, the company actually generated revenue in the amount of $289.5 million.
  • Guidance – As if strong revenue and earnings wasn’t enough, Horizon Pharma also released incredible guidance. The company said that during the full year, it is expecting to generate revenue in the range between $1.01 billion and $1.05 billion. Analysts are expecting to see $991.3 million. When it comes to EBITDA guidance, the company increased its full year figure from between $315 million and $350 million to between $340 million and $375 million.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will be keeping a close eye on HZNP. In particular, we’ll be watching to see if the company can continue this stellar performance throughout the rest of the year. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required









LEAVE A REPLY

Please enter your comment!
Please enter your name here